Committee advances measure to improve access to opioid overdose reversal medication
Loading...
Summary
The committee moved and advanced an act directing the Department of Mental Health and Addiction Services recommendations on access to opioid overdose reversal medication; the motion was seconded and advanced by roll call with no floor debate recorded.
The committee advanced an act reflecting the Department of Mental Health and Addiction Services’ recommendations aimed at improving access to opioid overdose reversal medication. Senator Amor moved the measure and Representative Kitt seconded it. The administrator conducted a roll‑call vote; the transcript records many members answering 'yes' with no substantive floor discussion recorded during committee consideration.
Why it matters: The measure focuses on ensuring access to naloxone (opioid overdose reversal medication) consistent with department recommendations. Expanding access to overdose reversal medication is a common public‑health response to rising opioid overdose rates and is intended to reduce fatal overdoses.
Procedure and next steps: The committee recorded the motion, second, and roll call. The chair noted votes will remain open for members who missed earlier voting. The bill text and any implementing details will be available for public hearing and possible amendment.
Actions and votes: Senator Amor moved the motion; Representative Kitt seconded. The administrator recorded roll‑call responses during the item. No amendments or extended debate on the substance were recorded in the transcript.
Quotes: No direct floor quotes addressing the substance of item 7 were recorded in the transcript.
